|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
+0.20% | +82.49% |
| 08-28 | Crinetics Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
| 08-04 | Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says | MT |
| Market Cap | 9B 7.75B 7.27B 6.64B 12.48B 856B 12.56B 86.21B 33.54B 434B 33.79B 33.05B 1,438B | P/E 2026 * |
-18.2x | P/E 2027 * | -20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 7.99B 6.88B 6.46B 5.9B 11.08B 761B 11.16B 76.57B 29.79B 386B 30.01B 29.36B 1,277B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 46.3x |
| Free-Float |
98.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Crinetics Pharmaceuticals, Inc.
| 1 day | +0.13% | ||
| 1 week | +0.20% | ||
| Current month | +1.71% | ||
| 1 month | +1.71% | ||
| 3 months | +146.09% | ||
| 6 months | +111.74% | ||
| Current year | +82.49% |
| 1 week | 84.78 |  | 85.01 |
| 1 month | 83.62 | | 85.01 |
| Current year | 32.3 | | 85.01 |
| 1 year | 31 | | 85.01 |
| 3 years | 15.76 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 62 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Free | Chief Financial Officer | 471 | 0.0004% | ||
| 8/7/26 | Exercice | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +0.20% | +155.11% | +390.47% | 9B | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +2.77% | -1.74% | -16.16% | +456.51% | 25.89B | |
| -0.46% | -9.94% | +0.98% | -15.98% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| +0.35% | +0.16% | +46.96% | +144.04% | 13.49B | |
| Average | -1.93% | -3.31% | +61.31% | +205.13% | 29.09B | |
| Weighted average by Cap. | -1.95% | -3.39% | +51.39% | +153.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.86M 66.18M 62.14M 56.72M 107M 7.31B 107M 736M 286M 3.71B 289M 282M 12.28B | 180M 155M 146M 133M 250M 17.17B 252M 1.73B 673M 8.71B 677M 663M 28.83B |
| Net income | -507M -437M -410M -374M -704M -48.28B -709M -4.86B -1.89B -24.48B -1.91B -1.86B -81.07B | -463M -399M -375M -342M -642M -44.09B -647M -4.44B -1.73B -22.36B -1.74B -1.7B -74.03B |
| Net Debt | -1.01B -866M -813M -742M -1.39B -95.66B -1.4B -9.63B -3.75B -48.51B -3.77B -3.69B -161B | -647M -557M -523M -477M -897M -61.56B -903M -6.2B -2.41B -31.22B -2.43B -2.38B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | US$84.95 | +0.13% | 8,204,934 |
| 26-08-28 | US$84.84 | -0.01% | 1,127,886 |
| 26-08-27 | US$84.85 | +0.01% | 1,058,995 |
| 26-08-26 | US$84.84 | -0.02% | 479,524 |
| 26-08-25 | US$84.86 | +0.09% | 1,241,641 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
